His primary areas of study are Immunology, Antibody, Immune system, Antigen and Proinflammatory cytokine. Autoantibody, IL-2 receptor, Immunotherapy, Common variable immunodeficiency and Immunodeficiency are subfields of Immunology in which his conducts study. His studies in IL-2 receptor integrate themes in fields like Experimental autoimmune encephalomyelitis, Multiple sclerosis and FOXP3.
His Antibody research includes elements of Immune homeostasis, Receptor and Disease. In Immune system, Sébastien Lacroix-Desmazes works on issues like Cell biology, which are connected to Chemokine and CD40. His research in Proinflammatory cytokine intersects with topics in Pathogenesis, T cell, Autoimmune hemolytic anemia, Heme and Effector.
Sébastien Lacroix-Desmazes spends much of his time researching Immunology, Antibody, Immune system, Antigen and Autoantibody. His study in Autoimmunity, Immunogenicity, Inflammation, Antigen-presenting cell and Immune tolerance are all subfields of Immunology. His Immunogenicity research is multidisciplinary, incorporating elements of Haemophilia A, Recombinant DNA, In vivo and Von Willebrand factor.
Sébastien Lacroix-Desmazes has researched Antibody in several fields, including Molecular biology, Biochemistry and Virology. His studies deal with areas such as Receptor, Coagulation and Cell biology as well as Immune system. His Antigen research includes themes of IL-2 receptor and Monoclonal antibody.
Sébastien Lacroix-Desmazes spends much of his time researching Antibody, Immunology, Immune system, Immunogenicity and Antigen. The various areas that Sébastien Lacroix-Desmazes examines in his Antibody study include In vitro, Computational biology and Virology. His research investigates the connection with Immunology and areas like Haemophilia A which intersect with concerns in Oncology and Internal medicine.
The study incorporates disciplines such as Cell biology, In vivo and Heme in addition to Immune system. His Immunogenicity research incorporates themes from Neutralizing antibody, Cervical dystonia, Glycosylation, Coagulation and Von Willebrand factor. His Epitope study combines topics from a wide range of disciplines, such as Molecular biology and Recombinant DNA.
Sébastien Lacroix-Desmazes mostly deals with Antibody, Immune system, Immunology, Antigen and Immunogenicity. His work deals with themes such as Endopeptidase, Virus, Virology, Immunosuppression and Genetic enhancement, which intersect with Antibody. The Immune system study combines topics in areas such as Epitope and B cell.
His work carried out in the field of Epitope brings together such families of science as Autoantibody, Molecular biology, Polyclonal antibodies, Autoimmunity and Immunotherapy. In his study, Vaccination is inextricably linked to Endogeny, which falls within the broad field of Immunology. His study in Immunogenicity is interdisciplinary in nature, drawing from both Immune tolerance, Coagulation and Von Willebrand factor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cutting Edge: Human CD4+CD25+ T Cells Restrain the Maturation and Antigen-Presenting Function of Dendritic Cells
Namita Misra;Jagadeesh Bayry;Sébastien Lacroix-Desmazes;Michel D. Kazatchkine.
Journal of Immunology (2004)
Self-reactive antibodies (natural autoantibodies) in healthy individuals
Sébastien Lacroix-Desmazes;Srini V Kaveri;Luc Mouthon;Ahidjo Ayouba.
Journal of Immunological Methods (1998)
Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin
Jagadeesh Bayry;Sébastien Lacroix-Desmazes;Cedric Carbonneil;Namita Misra.
Intravenous Immunoglobulin: An Update on the Clinical Use and Mechanisms of Action
Vir-Singh Negi;Sriramulu Elluru;Sophie Sibéril;Stéphanie Graff-Dubois.
Journal of Clinical Immunology (2007)
Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis.
Amal Ephrem;Souleima Chamat;Catherine Miquel;Sylvain Fisson;Sylvain Fisson;Sylvain Fisson.
Mechanisms of action of intravenous immune globulin in immune-mediated diseases
L. Mouthon;S. V. Kaveri;S. H. Spalter;S. Lacroix-Desmazes.
Clinical and Experimental Immunology (1996)
VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors.
Suryasarathi Dasgupta;Suryasarathi Dasgupta;Yohann Repessé;Yohann Repessé;Jagadeesh Bayry;Jagadeesh Bayry;Ana-Maria Navarrete;Ana-Maria Navarrete.
Catalytic activity of antibodies against factor VIII in patients with hemophilia A.
Sébastien Lacroix-Desmazes;Alexandre Moreau;Sooryanarayana;Cécile Bonnemain.
Nature Medicine (1999)
Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A.
A. Pavlova;D. Delev;S. Lacroix-Desmazes;R. Schwaab.
Journal of Thrombosis and Haemostasis (2009)
Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases.
J. Bayry;M. Thirion;N. Misra;N. Thorenoor.
Neurological Sciences (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: